Resverlogix Corp. (RVX.TO)
0.09
0.00 (0.00%)
CAD |
TSX |
Oct 02, 16:00
Resverlogix Net Income (Quarterly) : -8.421M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -8.421M |
| March 31, 2026 | -4.732M |
| December 31, 2025 | -0.2872M |
| September 30, 2025 | -1.310M |
| June 30, 2025 | -2.228M |
| March 31, 2025 | -7.176M |
| December 31, 2024 | 0.6531M |
| September 30, 2024 | -6.731M |
| June 30, 2024 | -6.167M |
| March 31, 2024 | 1.807M |
| December 31, 2023 | -4.255M |
| September 30, 2023 | -5.966M |
| June 30, 2023 | -5.391M |
| March 31, 2023 | -6.972M |
| December 31, 2022 | 1.087M |
| September 30, 2022 | -2.189M |
| June 30, 2022 | -0.5146M |
| March 31, 2022 | -2.954M |
| December 31, 2021 | -21.30M |
| September 30, 2021 | -6.661M |
| June 30, 2021 | -3.203M |
| March 31, 2021 | 0.0253M |
| April 30, 2020 | 12.02M |
| January 31, 2020 | 6.160M |
| October 31, 2019 | 133.25M |
| Date | Value |
|---|---|
| July 31, 2019 | 5.259M |
| April 30, 2019 | -80.85M |
| January 31, 2019 | -17.84M |
| October 31, 2018 | -51.07M |
| July 31, 2018 | -64.55M |
| April 30, 2018 | -10.47M |
| January 31, 2018 | -30.20M |
| October 31, 2017 | -13.60M |
| July 31, 2017 | -20.29M |
| April 30, 2017 | -15.40M |
| January 31, 2017 | -17.32M |
| October 31, 2016 | -19.88M |
| July 31, 2016 | -8.397M |
| April 30, 2016 | -12.86M |
| January 31, 2016 | -12.19M |
| October 31, 2015 | -5.008M |
| July 31, 2015 | 3.298M |
| April 30, 2015 | -24.91M |
| January 31, 2015 | -1.931M |
| October 31, 2014 | -3.69M |
| July 31, 2014 | 7.165M |
| April 30, 2014 | 0.4088M |
| January 31, 2014 | 16.34M |
| October 31, 2013 | -1.997M |
| July 31, 2013 | 42.67M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Spectral Medical, Inc. | 0.331M |
| Theratechnologies, Inc. | -6.276M |
| COSCIENS Biopharma, Inc. | -0.2796M |
| Restart Life Sciences Corp. | -1.017M |
| Covalon Technologies Ltd. | 2.811M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 8.421M |
| EPS Diluted (Quarterly) | -0.0256 |
| Enterprise Value | 141.14M |
| Earnings Yield | -52.11% |
| Normalized Earnings Yield | -51.89 |